People · Operator
Named in public records as an officer, director or promoter · active 2016–2021 · Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Axonius, Inc. | — | Other Technology | Series D+ | $570.5M | $705.0M | 2020 |
| Aquant, Inc. | — | Other Technology | Series C | $128.8M | $1.9B | 2020 |
| BookMD, Inc. | — | Other Technology | Series A | $11.1M | $306.8M | 2016 |
Tal Morgenstern at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tal Morgenstern on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Perlman | 1 | 15 |
| Peter Sobiloff | 1 | 13 |
| John Brennan | 1 | 9 |
| Ken Fox | 1 | 3 |
| Kenneth Fox | 1 | 3 |
| Abraham Schwartz | 1 | 2 |
| Kenneth A. Fox | 1 | 2 |
| Arsham Memarzadeh | 1 | 2 |
| Dean Sysman | 1 | 2 |
| Anne DelSanto | 1 | 2 |
| Wendy A. Zheng | 1 | 1 |
| Fred A. Ball | 1 | 1 |
| Anne A. Delsanto | 1 | 1 |
| Idit Mualem | 1 | 1 |
| Amit Karp | 1 | 1 |
| Matt A. Weigand | 1 | 1 |
| Matt Weigand | 1 | 1 |
| Yael Peled | 1 | 1 |
| JOHN MACKEY CRAVEN | 1 | 1 |
| ARSHAM MACKEY MEMARZADEH | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.